DK1246825T3 - Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf - Google Patents
Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse derafInfo
- Publication number
- DK1246825T3 DK1246825T3 DK01902310T DK01902310T DK1246825T3 DK 1246825 T3 DK1246825 T3 DK 1246825T3 DK 01902310 T DK01902310 T DK 01902310T DK 01902310 T DK01902310 T DK 01902310T DK 1246825 T3 DK1246825 T3 DK 1246825T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- pyrrole compounds
- pharmaceuticals containing
- condensed pyrrole
- relates
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 abstract 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 abstract 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 abstract 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 150000002478 indolizines Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003238 pyrrolizines Chemical class 0.000 abstract 1
- 230000000552 rheumatic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10001166A DE10001166A1 (de) | 2000-01-13 | 2000-01-13 | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
| PCT/EP2001/000332 WO2001051491A1 (de) | 2000-01-13 | 2001-01-12 | Anellierte pyrrolverbindungen, diese enthaltende pharmazeutische mittel und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1246825T3 true DK1246825T3 (da) | 2004-04-13 |
Family
ID=7627401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01902310T DK1246825T3 (da) | 2000-01-13 | 2001-01-12 | Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6936632B2 (da) |
| EP (1) | EP1246825B1 (da) |
| JP (1) | JP2003525875A (da) |
| KR (1) | KR20020081254A (da) |
| CN (1) | CN1191254C (da) |
| AT (1) | ATE256685T1 (da) |
| AU (1) | AU2001230180A1 (da) |
| CA (1) | CA2396413A1 (da) |
| DE (2) | DE10001166A1 (da) |
| DK (1) | DK1246825T3 (da) |
| ES (1) | ES2213102T3 (da) |
| MX (1) | MXPA02006863A (da) |
| NO (1) | NO323238B1 (da) |
| PT (1) | PT1246825E (da) |
| TR (1) | TR200400270T4 (da) |
| WO (1) | WO2001051491A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10004157A1 (de) | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
| CN1549711A (zh) * | 2001-08-30 | 2004-11-24 | ��Ĭ���� | 稠合的吡咯化合物在治疗关节软骨或软骨下骨组织退化中的用途 |
| US20070077297A1 (en) | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
| US20060068009A1 (en) * | 2004-09-30 | 2006-03-30 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
| US7749537B2 (en) * | 2006-12-04 | 2010-07-06 | Scolr Pharma, Inc. | Method of forming a tablet |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
| CN117756811A (zh) * | 2023-12-29 | 2024-03-26 | 贵州民族大学 | 一种合成多取代基吡咯化合物的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4232038A (en) * | 1979-08-31 | 1980-11-04 | Syntex (U.S.A.) Inc. | 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids |
| DE3361812D1 (en) | 1982-03-03 | 1986-02-27 | Du Pont | Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes |
| DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
| US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
| ATE160345T1 (de) | 1993-01-15 | 1997-12-15 | Searle & Co | 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel |
| US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5344991A (en) | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
| US5475018A (en) | 1993-11-30 | 1995-12-12 | G. D. Searle & Co. | 1,5-diphenyl pyrazole compounds for treatment of inflammation |
| ES2133740T3 (es) | 1994-02-10 | 1999-09-16 | Searle & Co | Espiro-compuestos sustituidos para el tratamiento de la inflamacion. |
| US5418254A (en) | 1994-05-04 | 1995-05-23 | G. D. Searle & Co. | Substituted cyclopentadienyl compounds for the treatment of inflammation |
| DE4419247A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie |
| DE4419246A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| DE4419315A1 (de) * | 1994-06-01 | 1995-12-07 | Merckle Gmbh | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
| US5593994A (en) | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
| ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
| DE19624290A1 (de) | 1996-06-18 | 1998-01-02 | Merckle Gmbh | Verwendungen von Pyrrolizin-Verbindungen in der Pharmazie |
| DE19624289A1 (de) | 1996-06-18 | 1998-01-02 | Merckle Gmbh | Pyrrolizin-Verbindungen und deren Verwendung |
| WO1999061016A1 (fr) * | 1998-05-27 | 1999-12-02 | Nippon Shinyaku Co., Ltd. | Inhibiteurs de cyclo-oxygenase-2 |
| DE19845446A1 (de) | 1998-10-02 | 2000-04-06 | Merckle Gmbh | Antiinflammatorische Oxo- und Hydroxyderivate von Pyrrolizinen und deren Verwendung in der Pharmazie |
| EP1232158B1 (de) | 1999-11-23 | 2004-02-25 | Merckle Gmbh | Antiinflammatorische oxo- und hydroxyderivate von pyrrolizinen und deren anwendung in der pharmazie |
| DE10004157A1 (de) | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
-
2000
- 2000-01-13 DE DE10001166A patent/DE10001166A1/de not_active Withdrawn
-
2001
- 2001-01-12 CN CNB018065279A patent/CN1191254C/zh not_active Expired - Fee Related
- 2001-01-12 US US10/169,988 patent/US6936632B2/en not_active Expired - Fee Related
- 2001-01-12 CA CA002396413A patent/CA2396413A1/en not_active Abandoned
- 2001-01-12 DK DK01902310T patent/DK1246825T3/da active
- 2001-01-12 TR TR2004/00270T patent/TR200400270T4/xx unknown
- 2001-01-12 KR KR1020027009012A patent/KR20020081254A/ko not_active Withdrawn
- 2001-01-12 MX MXPA02006863A patent/MXPA02006863A/es active IP Right Grant
- 2001-01-12 JP JP2001551075A patent/JP2003525875A/ja active Pending
- 2001-01-12 AU AU2001230180A patent/AU2001230180A1/en not_active Abandoned
- 2001-01-12 EP EP01902310A patent/EP1246825B1/de not_active Expired - Lifetime
- 2001-01-12 WO PCT/EP2001/000332 patent/WO2001051491A1/de not_active Ceased
- 2001-01-12 DE DE50101187T patent/DE50101187D1/de not_active Expired - Fee Related
- 2001-01-12 PT PT01902310T patent/PT1246825E/pt unknown
- 2001-01-12 ES ES01902310T patent/ES2213102T3/es not_active Expired - Lifetime
- 2001-01-12 AT AT01902310T patent/ATE256685T1/de not_active IP Right Cessation
-
2002
- 2002-07-12 NO NO20023363A patent/NO323238B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200400270T4 (tr) | 2004-03-22 |
| EP1246825B1 (de) | 2003-12-17 |
| JP2003525875A (ja) | 2003-09-02 |
| ATE256685T1 (de) | 2004-01-15 |
| US6936632B2 (en) | 2005-08-30 |
| PT1246825E (pt) | 2004-04-30 |
| EP1246825A1 (de) | 2002-10-09 |
| NO20023363D0 (no) | 2002-07-12 |
| WO2001051491A1 (de) | 2001-07-19 |
| ES2213102T3 (es) | 2004-08-16 |
| CN1191254C (zh) | 2005-03-02 |
| MXPA02006863A (es) | 2004-04-05 |
| DE50101187D1 (de) | 2004-01-29 |
| AU2001230180A1 (en) | 2001-07-24 |
| CA2396413A1 (en) | 2001-07-19 |
| DE10001166A1 (de) | 2001-07-19 |
| NO20023363L (no) | 2002-09-10 |
| US20040122002A1 (en) | 2004-06-24 |
| KR20020081254A (ko) | 2002-10-26 |
| CN1418217A (zh) | 2003-05-14 |
| NO323238B1 (no) | 2007-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1263730T3 (da) | Aminderivater til behandling af apoptose | |
| DE60142921D1 (de) | Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| NO20050525L (no) | Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer | |
| NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
| ATE369370T1 (de) | Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren | |
| NO20024614D0 (no) | N-heterosykliske derivater som NOS-hemmere | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| ATE301653T1 (de) | Pyrazolopyridine | |
| MXPA02011425A (es) | Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa. | |
| SE0300119D0 (sv) | Novel compounds | |
| NO20035583D0 (no) | Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner | |
| ATE332301T1 (de) | Antivirale pyrazolopyridin verbindungen | |
| DK1246809T3 (da) | 5-aryl-1H-1,2,4-triazolforbindelser som inhibitor for cyclooxygenase-2 og farmaceutiske sammensætninger som indeholder dem | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| DK1517890T3 (da) | Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| SE9804212D0 (sv) | Compounds | |
| NO20055612L (no) | Anti-inflammatoriske fosfonatforbindelser | |
| DK1246825T3 (da) | Kondenserede pyrrolforbindelser, farmaceutiske midler indeholdende dem og anvendelse deraf | |
| IL151198A0 (en) | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer | |
| ATE274515T1 (de) | Pyrazolopyridinderivate | |
| SE9904128D0 (sv) | Novel compounds |